8-K: Xtant Medical Secures $10.7M Payment, Cuts Debt

Xtant Medical Holdings, Inc. announced the full repayment of a $8.2 million promissory note and additional payments from Companion Spine, totaling $10.7 million, and used a portion to prepay its term loan.

Summary

• Xtant Medical Holdings, Inc. received a $10.7 million payment from Companion Spine on February 27, 2026.
• This payment included the full repayment of an $8.2 million unsecured promissory note, accrued interest thereon, and settlement of net working capital and other purchase price adjustments under the Paradigm purchase agreement.
• The total aggregate purchase price for the divestitures of Coflex and CoFix products and Paradigm Spine GmbH now stands at $21.4 million, an increase from the previously announced $19.2 million.
• $2.8 million of the received funds were used to prepay a portion of the company's term loan with MidCap Financial Trust.
• The remaining principal outstanding on the term loan is $11.1 million as of the date of the filing.

Sentiment

Score: 8

Explanation: StockSavvy.ai views this as a strong positive development, as Xtant Medical successfully collected a significant payment, including interest and favorable adjustments, and used a portion to reduce debt, improving its financial position.

Positives

• Full repayment of the $8.2 million promissory note, plus accrued interest, enhancing liquidity.
• Settlement of net working capital and other purchase price adjustments, increasing the total divestiture proceeds to $21.4 million from the initial $19.2 million.
• Reduction of term loan principal by $2.8 million, improving the company's debt position and financial leverage.

Future Outlook

No explicit forward-looking statements or guidance are provided in this filing, which serves as a factual update on a completed financial transaction.

Management Comments

• Sean E. Browne, President and Chief Executive Officer, signed the report on behalf of Xtant Medical Holdings, Inc.

Industry Context

StockSavvy.ai notes that the successful collection of deferred payments and the subsequent debt reduction by Xtant Medical reflect a positive step in optimizing its capital structure following strategic divestitures. This move aligns with a broader industry trend where medical device companies streamline portfolios to focus on core competencies and improve financial flexibility, especially in a competitive market.

Stakeholder Impact

• Shareholders: Positive impact due to improved financial health, reduced debt, and successful collection of divestiture proceeds.
• Creditors: Positive impact due to reduction in outstanding term loan principal.

Key Dates

Recommendation

The successful collection of a significant payment, exceeding the original promissory note amount due to interest and favorable adjustments, coupled with a substantial reduction in term loan debt, significantly strengthens Xtant Medical's balance sheet and liquidity. This positive financial event reduces risk and provides greater financial flexibility, making the stock more attractive to investors.

Keywords

Xtant Medical, XTNT, Companion Spine, Promissory Note, Debt Repayment, Asset Sale, Divestiture, Term Loan, MidCap Financial Trust, SEC Filing, 8-K